Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
La Radiologia Medica|December 3, 2014
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterographyLaura Maria Minordi, Franco Scaldaferri, Luigi Larosa, et al.Journal of Clinical Medicine|November 27, 2024
Clinical, Radiological, and Surgical Risk Factors for Endoscopic Anastomotic Recurrence Following Surgery in Crohn's DiseaseLaura Maria Minordi, Franco Sacchetti, Domenico Balzano, et al.Journal of Translational Medicine|July 11, 2015
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac diseaseAnna Chiara Piscaglia, Sergio Rutella, Lucrezia Laterza, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2020
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapyLucrezia Laterza, Maria Elena Ainora, Matteo Garcovich, et al.Inflammatory Bowel Diseases|December 10, 2020
Impact of the Trophic Effects of the Secretome From a Multistrain Probiotic Preparation on the Intestinal EpitheliaValentina Petito, Viviana Greco, Lucrezia Laterza, et al.Plos One|October 27, 2017
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with InfliximabFranco Scaldaferri, Daria D'Ambrosio, Grainne Holleran, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 26, 2022
Radiomics could predict surgery at 10 years in Crohn's diseaseLucrezia Laterza, Luca Boldrini, Huong Elena Tran, et al.Journal of Personalized Medicine|May 25, 2024
Histologic Disease Persists beyond Mucosal Healing and Could Predict Reactivation in Ulcerative ColitisLucrezia Laterza, Anna Chiara Piscaglia, Stefano Bibbò, et al.Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2023
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical RemissionLaura Parisio, Carlo Romano Settanni, Simone Varca, et al.Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|January 20, 2024
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patientsDaniele Napolitano, Carlo Romano Settanni, Laura Parisio, et al.Pageof 8